Evidence map›Paper›PMID 36387185›Full record

SynthesisFrontiers in oncology2022

Systematic review and meta-analysis of multiparametric MRI clear cell likelihood scores for classification of small renal masses.

Jun Tian, Feixiang Teng, Hongtao Xu, Dongliang Zhang, Yinxiu Chi, Hu Zhang

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Invited Commentary: MRI Clear Cell Likelihood Score for Indeterminate Solid Renal Masses: Is There a Path for Broad Clinical Adoption?Radiographics : a review publication of the Radiological Society of North America, Inc · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jun TianDepartment of Basic Medication, Jiangsu Vocational College of Medicine, Yancheng, China.
Feixiang TengDepartment of Basic Medication, Jiangsu Vocational College of Medicine, Yancheng, China.
Hongtao XuDepartment of Medical Imaging, Jiangsu Vocational College of Medicine, Yancheng, China.
Dongliang ZhangDepartment of Basic Medication, Jiangsu Vocational College of Medicine, Yancheng, China.
Yinxiu ChiDepartment of Basic Medication, Jiangsu Vocational College of Medicine, Yancheng, China.
Hu ZhangDepartment of Basic Medication, Jiangsu Vocational College of Medicine, Yancheng, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To systematically assess the multiparametric MRI clear cell likelihood score (ccLS) algorithm for the classification of small renal masses (SRM). Methods: We conducted an electronic literature search on Web of Science, MEDLINE (Ovid and PubMed), Cochrane Library, EMBASE, and Google Scholar to identify relevant articles from 2017 up to June 30, 2022. We included studies reporting the diagnostic performance of the ccLS for characterization of solid SRM. The bivariate model and hierarchical summary receiver operating characteristic (HSROC) model were used to pool sensitivity, specificity, positive likelihood ratio (LR+), negative likelihood ratio (LR-), and diagnostic odds ratio (DOR). The quality evaluation was performed with the Quality Assessment of Diagnostic Accuracy Studies-2 tool. Results: A total of 6 studies with 825 renal masses (785 patients) were included in the current meta-analysis. The pooled sensitivity and specificity for cT1a renal masses were 0.80 (95% CI 0.75-0.85) and 0.74 (95% CI 0.65-0.81) at the threshold of ccLS ≥4, the pooled LR+, LR-, and DOR were 3.04 (95% CI 2.34-3.95), 0.27 (95% CI 0.22-0.33), and 11.4 (95% CI 8.2-15.9), respectively. The area under the HSROC curve was 0.84 (95% CI 0.81-0.87). For all cT1 renal masses, the pooled sensitivity and specificity were 0.80 (95% CI 0.74-0.85) and 0.76 (95% CI 0.67-0.83). Conclusions: The ccLS had moderate to high accuracy for identifying ccRCC from other RCC subtypes and with a moderate inter-reader agreement. However, its diagnostic performance remain needs multi-center, large cohort studies to validate in the future.

Indexed as

classificationclear cell likelihood scoremeta-analysisMRIsmall renal mass

Identifiers

PMID36387185
PMCPMC9641245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.